CClinicalTrials.gg
CompletedNCT04151251ISLEEPUpdated May 16, 2023

Inpatient Sleep Loss: Educating and Empowering Patients

An interventional study of Patient Empowerment and Sleep Kit in Sleep, sponsored by University of Chicago. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-16.

Sponsored by University of Chicago · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
256
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

While many interventions have targeted hospital staff to improve sleep, few have been successful, and often suffer from limited adherence to staff protocols. Given preliminary data that suggests that empowered patients are more likely to obtain better sleep and have objectively lower noise levels in their rooms, it is plausible that partnering directly with patients can mitigate sleep loss and improve health outcomes. Patients will be randomized to receive the I-SLEEP education and empowerment program and test the effectiveness of this program on patient sleep and health outcome in the hospital and post-discharge. The aim of the project is to reduce environmental, healthcare-related, and patient-related factors that disrupt sleep of hospitalized patients by use of patient education and empowerment intervention.

02

Conditions studied

  • Sleep
03

In context

Lead sponsor

University of Chicago is the lead sponsor of 907 studies on the registry; 182 are open to participants now.

Of its 99 completed or terminated interventional studies of FDA-regulated products, 68 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Admitted to the general/hospitalist medicine departments
  • Stayed at least one night in hospital since admission

Exclusion criteria

Exclusion Criteria:

  • Admitted >72 hours ago
  • Patient has been diagnosed with a sleep disorder such as narcolepsy, insomnia, or sleep apnea
  • Patient was transferred from ICU or outside hospital
  • Patient under strict, droplet, or airborne isolation precautions
  • Unable to ambulate
  • Too confused or incoherent to provide consent
  • Patient cannot speak English
  • Pregnancy
  • Residence in a nursing home or assisted living facility
  • Patient was admitted in a hospital within two weeks of current admission
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
256 participants (actual)

Study arms

  • Active comparator
    Sleep Kit Alone

    Patients who are not randomized into the I-SLEEP intervention will receive a sleep kit that includes an eye mask, earplugs, and headphones.They will still receive the usual standard of care provided by clinicians which includes measures to reduce unnecessary nighttime disruptions and limiting excessive noise within the hospital setting.

    Other: Sleep Kit

  • Experimental
    Sleep Kit + Empowerment

    A short video will be shown on iPads and a brochure will be given that both describe the importance of good sleep and how to facilitate it with good sleep hygiene. The video will show a few reasons why someone might not get optimal sleep while in a hospital, and offer advice to address this from a doctor. The brochure will be kept to no higher than a 6th grade reading level, considered optimal for health education materials. Text will be kept brief and to the point. To account for vision problems, we will use \>12-point font \& leave a large portion of each page empty. Visual Aids \& graphics will be employed when possible. All of this is given in addition to the usual standard of care provided by clinicians.

    Behavioral: Patient Empowerment · Other: Sleep Kit

Interventions

  • BehavioralPatient Empowerment

    Group to receive a 5 minute video about typical hospital sleep disruptions and what they can do to prevent them, as well as a brochure outlining the importance of sleep

  • OtherSleep Kit

    Patients receive a small pouch that includes an eye mask, ear plugs, and headphones, all to be used to aid in falling/staying asleep

06

What researchers measure

Primary outcomes

  1. Karolinska Sleep Log - Sleep Times

    A self-reported measure of time spent sleeping, time it took to fall asleep, etc.

    Time frame: Through stay in the hospital until discharge, usually 2-3 days

Secondary outcomes

  1. Frequency of Sleep Disruptions in the Hospital Setting

    Administered to obtain a subjective view of typical disruptions to sleep such as bed comfort, room temperature, and pain. Items will also assess the disruptions that are caused by healthcare, such as vital signs, medication administration, and lab-work. This survey includes an item on how disruptive noise was to the patient's sleep, broken down into as many sources of hospital noise as possible.

    Time frame: Through stay in the hospital until discharge, usually 2-3 days

  2. Patients Who Report Talking to Clinicians About Their Healthcare

    Measure of number of patients who advocate for their sleep by making lifestyle changes, including speaking to their clinicians to reduce nighttime disruptions

    Time frame: Through stay in the hospital until discharge, usually 2-3 days

  3. Number of nighttime disruptions to sleep

    Measure of disruptions patients receive between 11 PM and 7 AM, determined by hospital hand sanitizer stations outside doors and electronic health record audits

    Time frame: Through stay in the hospital until discharge, usually 2-3 days

  4. Karolinska Sleep Log - Outcomes of Sleep

    Subjective quality of sleep as determined by scales such as "On a scale of 1 to 5, with 5 being the most, how refreshed did you feel upon waking up this morning?"

    Time frame: Through stay in the hospital until discharge, usually 2-3 days

  5. Actigraphy - Objective Measure of Sleep Duration

    Actiwatch Spectrum Pros used to determine sleep duration

    Time frame: During stay at the hospital, for a week after, and for a week three months after discharge

  6. Actigraphy - Objective Measure of Sleep Quality

    Actiwatch Spectrum Pros used to determine sleep quality

    Time frame: During stay at the hospital, for a week after, and for a week three months after discharge

07

Study locations

1 site
  • University of Chicago Medical Center
    Chicago, Illinois 60637, United States
08

References and documents

Publications

  • Arora VM, Machado N, Anderson SL, Desai N, Marsack W, Blossomgame S, Tuvilleja A, Ramos J, Francisco MA, LaFond C, Leung EK, Valencia A, Martin SK, Meltzer DO, Farnan JM, Balachandran J, Knutson KL, Mokhlesi B. Effectiveness of SIESTA on Objective and Subjective Metrics of Nighttime Hospital Sleep Disruptors. J Hosp Med. 2019 Jan;14(1):38-41. doi: 10.12788/jhm.3091. PubMed 30667409 ↗
  • Adachi M, Staisiunas PG, Knutson KL, Beveridge C, Meltzer DO, Arora VM. Perceived control and sleep in hospitalized older adults: a sound hypothesis? J Hosp Med. 2013 Apr;8(4):184-90. doi: 10.1002/jhm.2027. Epub 2013 Mar 18. PubMed 23504939 ↗
  • Mason NR, Orlov NM, Anderson S, Byron M, Mozer C, Arora VM. Piloting I-SLEEP: a patient-centered education and empowerment intervention to improve patients' in-hospital sleep. Pilot Feasibility Stud. 2021 Aug 19;7(1):161. doi: 10.1186/s40814-021-00895-z. PubMed 34412696 ↗

Study documents

  • Informed consent form · Dec 7, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided — Deidentified data will be available to researchers by request

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 16, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04151251
Lead sponsor
University of Chicago
Responsible party
Sponsor
First posted
Nov 5, 2019
Start date
Jan 8, 2020
Primary completion
Mar 31, 2023
Completion
Mar 31, 2023
Last update
May 16, 2023

Study contacts

Vineet Arora, MD, MAPP
principal investigator · Medical Researcher

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion